View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches

  • May 23, 2013

  • The Disruptive Innovations to Advance Clinical Trials (DPharm) event is the definitive conference committed to transforming the clinical trial enterprise with bold ideas through an original interactive format. The entire program is dedicated to presenting disruptive ideas to greatly enhance the industry’s ability to achieve clinical operational excellence.


    New York (PRWEB) May 22, 2013

    The Conference Forum announced the launch of the 3rd Annual Disruptive Innovations to Advance Clinical Trials conference taking place on September 19-20 at the Fairmont Copley Plaza Hotel in Boston, MA.

    Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, Genzyme, Janssen Pharmaceuticals and more share bold approaches to reduce expensive infrastructure, engage patients and generate credible clinical data.

    “Disruptive innovation needs to be big, or novel, or it must change the very nature of how we do clinical development,” explains Dr Andreas Koester, VP, Clinical Trial Innovation & External Alliances, Janssen Pharmaceutical, one of the event’s co-chairs.

    New sessions for the 2013 event include:
    *How Not to Do a Traditional Clinical Trial
    *Alternative Clinical Settings: The Walgreens-Novartis Collaboration
    *Keynote Fireside Chat with Google Ventures on Disruption in Drug development, New Approaches with Mobile Technologies and the Big Data Revolution
    *An Interview Series with Disruptive Thinkers from Medimmune, VA Boston Healthcare and the Center for Connected Health

    “We are particularly excited to welcome Zen Chu, Faculty Director and Entrepreneur-In-Residence from MIT to present the results of a hackathon on the topic of clinical trials, and Dr John J. Whyte, Chief Medical Expert & VP, Health and Medical Education at Discovery Channel for the interview series,” explains Valerie Bowling, Event Director.

    The event expects to attract over 300 disruptive thinkers from pharmaceutical, biotech and technology companies seeking disruptive ideas to change the pace of clinical trials.

    For more information, visit

    About The Conference Forum:
    The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.